Buy VIP 6mg – Peptide Science

VIP 6mg (Vasoactive Intestinal Peptide) Overview

VIP 6mg from Peptide Science is the synthetic 28-amino-acid native human vasoactive intestinal peptide, supplied as a lyophilised vial for in-vitro receptor-binding and preclinical neuroendocrine research. The peptide was originally isolated from the porcine intestine and is now characterised as a widely-distributed hypothalamic and gastrointestinal neuropeptide.

Compound Class and Mechanism

VIP binds two G-protein-coupled receptors (VPAC1 and VPAC2) with similar affinity, triggering adenylate cyclase and the downstream cAMP-PKA signalling cascade. The peptide is studied in preclinical research for effects on vasodilation, gastrointestinal motility, neurotransmitter release in the central nervous system, and circadian-rhythm regulation through suprachiasmatic-nucleus VIP-expressing neurons. VIP is structurally related to PACAP (pituitary adenylate cyclase-activating polypeptide) in the secretin / glucagon receptor family. Browse the broader healing peptide range.

Specifications

For paired research with adjacent secretin-family research peptides, see Sermorelin 5mg (GHRH family).

Reconstitution and Handling

The lyophilised vial reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. Aliquoting reconstituted stock for single-use frozen storage is the standard preclinical handling practice for short-sequence peptides.

Quality and Shipping

Each batch passes HPLC at greater than 99 percent purity, with mass-spectrometry identity confirmation. A Certificate of Analysis accompanies every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging.

For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws.